The activation of G protein-coupled receptor 30 increases pro-opiomelanocortin gene expression through cAMP/PKA/NR4A pathway in mouse pituitary corticotroph AtT-20 cells
Open Access
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 739, 135468
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The G-protein-coupled estrogen receptor GPER in health and diseaseNature Reviews Endocrinology, 2011
- The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell CycleJournal of Vascular Research, 2011
- Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrestCell Death & Differentiation, 2010
- The G Protein–Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor–Positive Breast Cancer CellsCancer Research, 2010
- Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosisJournal of Neuroimmunology, 2009
- Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissuesJournal of Endocrinology, 2009
- Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamusNeuroscience, 2009
- GPR30 Contributes to Estrogen-Induced Thymic AtrophyMolecular Endocrinology, 2008
- Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing diseaseGenes & Development, 2006
- Identification of a Gene (GPR30) with Homology to the G-Protein-Coupled Receptor Superfamily Associated with Estrogen Receptor Expression in Breast CancerGenomics, 1997